Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:09 AM
Ignite Modification Date:
2025-12-25 @ 3:09 AM
NCT ID:
NCT05082805
Eligibility Criteria:
Inclusion Criteria:
* Major patient (age ≥ 18 years)
* Patient with RA according to American College of Rheumatology (ACR) / European Congress of Rheumatology (EULAR) 2010 or ACR 1987 or patient with PsA according to ClASsification criteria for Psoriatic ARthritis (CASPAR) criteria
* Patient undergoing treatment with methotrexate (MTX) (oral or injectable) initiated for at least 3 months.
* Naïve patient of biotherapy or tsDMARD and requiring the introduction of a first bDMARD or tsDMARD due to the activity of the disease.
* Patient informed and accepting the computer processing of his/her medical data and informed of his/her rights of access and rectification.
Exclusion Criteria:
* Patient participating in an interventional study in rheumatology
* Patient with axial spondyloarthritis (for patients with PsA)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05082805
Study Brief:
Protocol Section:
NCT05082805